BASF bids €664m for omega-3 company


BASF is to spend €664 million (£530 million) to buy Norwegian firm Pronova BioPharma, which specialises in omega-3 fatty acids. It has the backing of the Pronova board and shareholders representing 60% of the company, including private equity fund Herkules, which owns a 50% stake.

Pronova makes active pharmaceutical ingredients based on omega-3 fatty acids that are used to treat cardiovascular conditions. It also makes dietary supplements.

BASF says that omega-3 fatty acids represent a growing market. The company gained a significant stake in the market through its €3.1 billion purchase of german speciality chemical company Cognis in 2010. It strengthened its position in May this year when it bought UK firm Equateq.

Pronova employs 300 people and makes annual sales of about NOK1.7 billion (£180 million).


Related Content

BASF ups Pronova bid

16 January 2013 Business

news image

Pronova BioPharma specialises in omega-3 fatty acids

BASF to cut 260 jobs in nutrition and health

1 May 2014 Business

news image

Firm to sell Norwegian site and shift focus towards Asia

Most Read

Perovskite solar cells show hydrogen production promise

26 September 2014 Research

news image

Highly efficient solar cells and catalysts made from cheap, common materials use sunlight to split water

Big name coffee chains drawn into acrylamide fight

23 September 2014 News and Analysis

news image

Starbucks and other coffee chains are being sued in California by a non-profit that wants carcinogen labels slapped on their ...

Most Commented

Perovskite solar cells show hydrogen production promise

26 September 2014 Research

news image

Highly efficient solar cells and catalysts made from cheap, common materials use sunlight to split water

First interstellar sighting of a branched alkyl molecule

25 September 2014 Research

news image

Discovery shows that stellar nurseries could hold amino acids too that might have been the spark for life on Earth